Please Wait.....
Report
Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & marketing, Drug Safety), End User (Pharma, Medical Device), & Region - Global Forecast to 2029
Market Reprt I 2025-02-01 I 390 Pages I MarketsandMarkets
The global Life science analytics market is projected to reach USD 61.94 billion by 2029 from USD 35.69 billion in 2024, at a CAGR of 11.7% during the forecast period. The market is expected to grow as a result of the heterogenity & complexity of big data in life sciences, surging demand for technologically advanced analytical solutions for various applications across the industry, such as, research & development, commercialization (market access, pricing, sales & marketing, etc), safety, among others. Moreover, the market has experienced growth due to the need for improved data standardization across the life science & healthcare industry. However, insufficient IT infrastructure, and reluctance towards adoption of analytics solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.
"Software-as-a-service (SaaS) subsegment, under the life science analytics software segment is expected to register highest growth during the forecast period."
The life science analytics software segment is sub-segmented into on-premise, cloud-based, and software-as-a-service. In 2023, the software-as-a-service (SaaS) segment is expected to register the highest growth during the forecast period. The growth of the SaaS segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various cloud silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, several applications offered by the SaaS model, spanning areas such as accounting, performance monitoring, and communication through webmail and instant messengers, further contribute to the segment's growth.
"Pharmaceutical & Biotechnology companies is projected to dominate the market in the life science analytics market, by end user during the forecast period."
The pharmaceutical & biotechnology companies, medical device companies, research institutes, and outsourced life science organizations such as CROS, CMOs, independent contractors, etc., make up the end user segments of the life science analytics market. In 2023, the pharmaceutical & biotechnology companies accounted for a significant share of the life science analytics market, by end user. The segment is also expected to register paramount growth during the forecast period. The prominent position & high growth of this segment is due to the increasing R&D expenditure of pharma & biotech companies, the increasing use of analytics for research & development processes, pharma sales and marketing, growing importance of analytics in pharmacovigilance, the need to accelerate drug discovery, optimize clinical trials, and enhance regulatory compliance through data-driven insights. Moreover, the push for personalized medicine and precision therapeutics, The integration of Al and machine learning further strengthens the value of analytics in the pharma & biotech industry.
"Asia Pacific is expected to register highest market growth during the forecast period."
The life science analytics market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register highest growth during the forecast period. The high growth of this region is attributed to the the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across life science industry, and significant focus on integrating sophisticated technologies across the workflows also contributes to the growth.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
- By Designation - Directors: 30%, Manager: 34%, and Others: 36%
- By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%
List of Companies Profiled in the Report
o Oracle (US)
o Merative (formerly IBM) (US)
o SAS Institute (US)
o Accenture (Ireland)
o IQVIA (US)
o Cognizant (US)
o Wipro (India)
o Veradigm (US)
o Optum (US)
o Microsoft (US)
o MaxisIT (US)
o ExlService Holdings (US)
o Inovalon (US)
o CitiusTech (US)
o Saama (US)
o Axtria (US)
o Clarivate (UK)
o ThoughtSphere (US)
o ThoughtSpot (US)
o Salesforce (US)
o Google LLC (US)
o Amazon Web Services, Inc. (US)
o Veeva Systems (US)
o Elsevier (Netherlands)
o Komodo Health, Inc. (US)
Research Coverage:
The report analyzes the Life science analytics market and aims to estimate the market size and future growth potential of various market segments, based on type, component, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total life science analytics market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (rising pressure to curb healthcare spending, need for improved data standardization, technological advancements in analytical solutions, heterogeneity and complexity of big data in life sciences, growing adoption of analytical solutions in clinical trials, increasing R&D expenditure in pharmaceutical & biotechnology companies), restraints (high implementation costs of advanced analytical solutions, data privacy concerns), opportunities (growing focus on value-based care, use of analytics in precision & personalized medicine, big data analytics for R&D productivity, growing adoption of cloud-based analytics), challenges (issues associated with data integration, shortage of skilled personnel, reluctance to adopt life science analytics solutions in emerging countries) are factors contributing the growth of the life science analytics market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the life science analytics market.
- Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
- Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the life science analytics market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global life science analytics market such as Oracle (US), Merative (formerly IBM) (US), SAS Institute (US), Accenture (Ireland), IQVIA (US), Cognizant (US), Wipro (India), Veradigm (US), Optum (US).
1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 INCLUSIONS & EXCLUSIONS 39
1.3.3 YEARS CONSIDERED 39
1.3.4 CURRENCY CONSIDERED 40
1.4 STAKEHOLDERS 40
1.5 SUMMARY OF CHANGES 41
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Key data from secondary sources 44
2.1.2 PRIMARY DATA 44
2.1.2.1 Key industry insights 46
2.2 MARKET SIZE ESTIMATION 47
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 52
2.4 MARKET SHARE ESTIMATION 54
2.5 STUDY ASSUMPTIONS 54
2.6 LIMITATIONS 54
2.6.1 METHODOLOGY-RELATED LIMITATIONS 54
2.6.2 SCOPE-RELATED LIMITATIONS 54
2.7 RISK ASSESSMENT 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 60
4.1 LIFE SCIENCE ANALYTICS MARKET OVERVIEW 60
4.2 LIFE SCIENCE ANALYTICS MARKET, BY REGION 61
4.3 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER & REGION 61
4.4 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHIC SNAPSHOT 62
4.5 LIFE SCIENCE ANALYTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 62
?
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
5.2.1 DRIVERS 64
5.2.1.1 Rising pressure to curb healthcare spending 64
5.2.1.2 Need for improved data standardization 64
5.2.1.3 Technological advancements in analytical solutions 65
5.2.1.4 Heterogeneity and complexity of big data in life sciences 66
5.2.1.5 Growing adoption of analytical solutions in clinical trials 66
5.2.1.6 Increasing R&D expenditure in pharmaceutical & biotechnology companies 67
5.2.2 RESTRAINTS 68
5.2.2.1 High implementation costs of advanced analytical solutions 68
5.2.2.2 Data privacy concerns 68
5.2.3 OPPORTUNITIES 70
5.2.3.1 Growing focus on value-based care 70
5.2.3.2 Use of analytics in precision & personalized medicine 70
5.2.3.3 Big data analytics for R&D productivity 71
5.2.3.4 Growing adoption of cloud-based analytics 72
5.2.4 CHALLENGES 72
5.2.4.1 Issues associated with data integration 72
5.2.4.2 Shortage of skilled personnel 73
5.2.4.3 Reluctance to adopt life science analytics solutions in emerging countries 73
5.3 INDUSTRY TRENDS 74
5.3.1 GROWING ADOPTION OF ANALYTICS IN COMMERCIAL OPERATIONS 74
5.3.2 LEVERAGING DATA & ANALYTICS TO ACCELERATE DRUG DISCOVERY & DEVELOPMENT 75
5.3.3 FOCUS ON REAL-TIME DATA ANALYTICS 75
5.4 TECHNOLOGY ANALYSIS 76
5.4.1 KEY TECHNOLOGIES 76
5.4.1.1 Artificial intelligence and machine learning 76
5.4.1.2 Big data analytics 76
5.4.1.3 Quantum computing 77
5.4.2 COMPLEMENTARY TECHNOLOGIES 77
5.4.2.1 Bioinformatics tools 77
5.4.2.2 Internet of things 77
5.4.3 ADJACENT TECHNOLOGIES 78
5.4.3.1 Blockchain 78
?
5.5 ECOSYSTEM ANALYSIS 78
5.6 VALUE CHAIN ANALYSIS 80
5.7 PORTER'S FIVE FORCES ANALYSIS 82
5.7.1 THREAT OF NEW ENTRANTS 83
5.7.2 THREAT OF SUBSTITUTES 83
5.7.3 BARGAINING POWER OF SUPPLIERS 83
5.7.4 BARGAINING POWER OF BUYERS 83
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 84
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 84
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
5.8.2 BUYING CRITERIA 85
5.9 CASE STUDY ANALYSIS 86
5.9.1 NOVARTIS USES MULTI-CLOUD DATA ANALYTICS PLATFORM TO OPTIMIZE OPERATIONS AND ACCELERATE INNOVATION 86
5.9.2 SAS VISUAL ANALYTICS HELPS MAXIMIZE PROFITABILITY THROUGH PRESCRIPTIVE ANALYTICS & DATA VISUALIZATION 87
5.9.3 STREAMLINING REGULATORY MONITORING AND IMPACT ASSESSMENTS: GEDEON RICHTER'S PARTNERSHIP WITH CLARIVATE 88
5.10 REGULATORY LANDSCAPE 89
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
5.10.2 NORTH AMERICA 91
5.10.3 EUROPE 92
5.10.4 ASIA PACIFIC 92
5.10.5 MIDDLE EAST & AFRICA 93
5.10.6 LATIN AMERICA 93
5.11 PRICING ANALYSIS 94
5.11.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION 95
5.11.2 AVERAGE SELLING PRICE, BY REGION 95
5.12 KEY CONFERENCES AND EVENTS, 2024-2025 96
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 97
5.14 PATENT ANALYSIS 97
5.14.1 PATENT PUBLICATION TRENDS 97
5.14.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES 98
5.14.3 MAJOR PATENTS 99
5.15 END USER ANALYSIS 100
5.15.1 UNMET NEEDS 100
5.15.2 END-USER EXPECTATIONS 102
5.16 LIFE SCIENCE ANALYTICS BUSINESS MODELS 103
5.16.1 SUBSCRIPTION-BASED MODEL 103
5.16.2 SAAS MODEL 103
5.16.3 PAY-PER-USE/USAGE-BASED MODEL 103
5.16.4 ENTERPRISE LICENSING 103
5.16.5 FREEMIUM MODEL 103
5.16.6 ENTERPRISE LICENSING 103
5.16.7 CONCURRENT LICENSING 104
5.16.8 CONSULTING SERVICES MODEL 104
5.16.9 PARTNERSHIP/REVENUE-SHARING MODEL 104
5.16.10 HYBRID MODELS 104
5.17 INVESTMENT & FUNDING SCENARIO 104
5.18 IMPACT OF AI/GENERATIVE AI ON LIFE SCIENCE ANALYTICS MARKET 107
5.18.1 TOP USE CASES & MARKET POTENTIAL 107
5.18.1.1 Key use cases 108
5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 110
5.18.2.1 Case Study 1: Knowledge Mining for a Global Biopharmaceutical Company 110
5.18.2.2 Healthcare analytics market 111
5.18.3 USER READINESS AND IMPACT ASSESSMENT 112
5.18.3.1 User readiness 112
5.18.3.1.1 Pharmaceutical & biotechnology companies 112
5.18.3.1.2 Medical device companies 112
5.18.3.1.3 Research centers 112
5.18.3.1.4 Outsourced life science organizations 112
5.18.3.2 Impact assessment 113
5.18.3.2.1 User A: Pharmaceutical & biotechnology companies 113
5.18.3.2.1.1 Implementation 113
5.18.3.2.1.2 Impact 113
5.18.3.2.2 User B: Medical device companies 114
5.18.3.2.2.1 Implementation 114
5.18.3.2.2.2 Impact 114
5.18.3.2.3 User C: Research institutes 115
5.18.3.2.3.1 Implementation 115
5.18.3.2.3.2 Impact 115
5.18.3.2.4 User D: Outsourced life science organizations 116
5.18.3.2.4.1 Implementation 116
5.18.3.2.4.2 Impact 116
6 LIFE SCIENCE ANALYTICS MARKET, BY TYPE 117
6.1 INTRODUCTION 118
6.2 DESCRIPTIVE ANALYTICS 118
6.2.1 ADVANCED VISUAL DATA EXPLORATION AND SUPPORT FOR INNOVATION TO DRIVE DEMAND 118
6.3 PREDICTIVE ANALYTICS 120
6.3.1 SIMULATION DEVELOPMENT FOR PREDICTING FUTURE TRENDS TO PROPEL MARKET GROWTH 120
?
6.4 PRESCRIPTIVE ANALYTICS 121
6.4.1 REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO SUPPORT MARKET GROWTH 121
7 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 123
7.1 INTRODUCTION 124
7.2 SERVICES 124
7.2.1 MANAGED SERVICES 126
7.2.1.1 Analytical services 127
7.2.1.1.1 Focus on expediting approvals and product launches to drive growth 127
7.2.1.2 Consulting services 128
7.2.1.2.1 Support for R&D, process development, and other workflow processes to drive market 128
7.2.2 PROFESSIONAL SERVICES 129
7.2.2.1 Training & implementation 131
7.2.2.1.1 Stringent regulations, increasing competition, and need for skill development to propel demand 131
7.2.2.2 Maintenance & support services 132
7.2.2.2.1 Rising complexity of analytical technologies and expanding research needs to support market growth 132
7.2.2.3 Other professional services 133
7.3 SOFTWARE 134
7.3.1 ON-PREMISE SOLUTIONS 135
7.3.1.1 Provision of multivendor architecture and security benefits to drive market 135
7.3.2 CLOUD-BASED SOLUTIONS 136
7.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption 136
7.3.3 SAAS-BASED SOLUTIONS 138
7.3.3.1 Increasing adoption of digital solutions and advantages of cloud-based models to drive growth 138
8 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 139
8.1 INTRODUCTION 140
8.2 RESEARCH & DEVELOPMENT 140
8.2.1 CLINICAL TRIALS 143
8.2.1.1 Life science analytics market for clinical trials, by type 144
8.2.1.1.1 Laboratory services 145
8.2.1.1.1.1 Better accuracy, efficiency, and data interpretation to support demand for lab services 145
8.2.1.1.2 Patient recruitment services 146
8.2.1.1.2.1 Need for better candidate identification and enrollment forecasting to propel market growth 146
8.2.1.1.3 Site identification services 147
8.2.1.1.3.1 Benefits in locating ideal trial sites and interpreting data to support adoption 147
8.2.1.1.4 Other clinical trial services 148
8.2.1.2 Life science analytics market for clinical trials, by phase 149
8.2.1.2.1 PHASE I 149
8.2.1.2.1.1 Strong pipeline of pharmaceutical companies to propel market growth 149
8.2.1.2.2 PHASE II 150
8.2.1.2.2.1 Extended duration of phase II studies to create growth opportunities for CROs 150
8.2.1.2.3 PHASE III 151
8.2.1.2.3.1 Rising trial expenditure to drive demand for cost-effective clinical research services 151
8.2.2 PRECLINICAL & DRUG DISCOVERY 152
8.2.2.1 Ability to assist researchers in process innovation and decision support to drive adoption 152
8.3 COMMERCIAL ANALYTICS 154
8.3.1 SALES & MARKETING SUPPORT 156
8.3.1.1 Rising analysis of digital marketing effectiveness to drive adoption 156
8.3.2 MARKET ACCESS 157
8.3.2.1 Focus on strategic pricing, reimbursement, and policy changes to support market growth 157
8.3.3 RWE & VALUE EVIDENCE 158
8.3.3.1 Increased data integration, partnerships, and technological to propel use of RWE 158
8.3.4 ENGAGEMENT SERVICES 159
8.3.4.1 Need for better patient engagement, digital advancements, and AI integration to propel market 159
8.4 REGULATORY COMPLIANCE 160
8.4.1 STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE TO DRIVE ADOPTION 160
8.5 MANUFACTURING & SUPPLY CHAIN OPTIMIZATION 162
8.5.1 RISING NEED FOR REDUCING LOGISTICS COSTS TO SUPPORT MARKET GROWTH 162
8.6 SAFETY 164
8.6.1 PHARMACOVIGILANCE 165
8.6.1.1 Monitoring of drug trials and medication programs to fuel market uptake 165
8.6.2 MEDICAL DEVICE SAFETY 166
8.6.2.1 Stringent safety standards, rigorous risk assessments, and robust quality control to drive demand 166
8.6.3 DIAGNOSTIC VIGILANCE 167
8.6.3.1 Continuous monitoring, integration of diverse data sources, and ongoing education to enhance accuracy and thoroughness 167
?
9 LIFE SCIENCE ANALYTICS MARKET, BY END USER 169
9.1 INTRODUCTION 170
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 170
9.2.1 RISING NEED FOR INNOVATIVE THERAPIES TO DRIVE ANALYTICS USAGE IN PRODUCT DEVELOPMENT 170
9.3 MEDICAL DEVICE COMPANIES 172
9.3.1 ADOPTION OF DATA ANALYTICS FOR DEVICE COMMERCIALIZATION TO DRIVE MARKET 172
9.4 RESEARCH CENTERS 173
9.4.1 NEED FOR ANALYZING LARGE VOLUMES OF DATA TO SUPPORT MARKET GROWTH 173
9.5 OUTSOURCED LIFE SCIENCE ORGANIZATIONS 174
9.5.1 RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET 174
10 LIFE SCIENCE ANALYTICS MARKET, BY REGION 175
10.1 INTRODUCTION 176
10.2 NORTH AMERICA 176
10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 177
10.2.2 US 183
10.2.2.1 Established economy and increasing R&D expenditure to drive adoption of analytical solutions 183
10.2.3 CANADA 188
10.2.3.1 Rising need for data standardization in life sciences to fuel uptake 188
10.3 EUROPE 193
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 193
10.3.2 GERMANY 198
10.3.2.1 Growing R&D investments by pharmaceutical & biotechnology companies to drive market 198
10.3.3 FRANCE 203
10.3.3.1 Growing government support for adoption of AI & big data analytics to drive market 203
10.3.4 UK 208
10.3.4.1 Rising clinical trial activity to drive uptake of life science analytics solutions 208
10.3.5 ITALY 213
10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions 213
10.3.6 SPAIN 217
10.3.6.1 Surging government investments focusing on personalized medicine to drive growth 217
10.3.7 REST OF EUROPE 222
?
10.4 ASIA PACIFIC 226
10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 227
10.4.2 JAPAN 233
10.4.2.1 Growing government support for clinical R&D activities to drive adoption 233
10.4.3 CHINA 238
10.4.3.1 Growth in life science industry to support adoption of solutions 238
10.4.4 INDIA 243
10.4.4.1 Rising R&D expenditure and drug development to support market growth 243
10.4.5 REST OF ASIA PACIFIC 248
10.5 LATIN AMERICA 253
10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 253
10.5.2 BRAZIL 258
10.5.2.1 Brazil to dominate life science analytics market in Latin America 258
10.5.3 MEXICO 263
10.5.3.1 Growing prominence of startups and rising R&D activity to propel market 263
10.5.4 REST OF LATIN AMERICA 268
10.6 MIDDLE EAST & AFRICA 273
10.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 273
10.6.2 GCC COUNTRIES 279
10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market 279
10.6.3 REST OF MIDDLE EAST & AFRICA 284
11 COMPETITIVE LANDSCAPE 289
11.1 OVERVIEW 289
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 289
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET 290
11.3 REVENUE ANALYSIS 291
11.4 MARKET SHARE ANALYSIS 292
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 293
11.5.1 STARS 294
11.5.2 EMERGING LEADERS 294
11.5.3 PERVASIVE PLAYERS 294
11.5.4 PARTICIPANTS 294
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 296
11.5.5.1 Company footprint 296
11.5.5.2 Type footprint 297
11.5.5.3 Application footprint 298
?
11.5.5.4 Component footprint 299
11.5.5.5 End user footprint 300
11.5.5.6 Region footprint 301
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 302
11.6.1 PROGRESSIVE COMPANIES 302
11.6.2 RESPONSIVE COMPANIES 302
11.6.3 DYNAMIC COMPANIES 302
11.6.4 STARTING BLOCKS 302
11.6.5 COMPETITIVE BENCHMARKING 304
11.7 BRAND/SOFTWARE COMPARATIVE ANALYSIS 306
11.8 VALUATION & FINANCIAL METRICS 307
11.9 COMPETITIVE SCENARIO 308
11.9.1 PRODUCT LAUNCHES & ENHANCEMENTS 308
11.9.2 DEALS 309
12 COMPANY PROFILES 311
12.1 KEY PLAYERS 311
12.1.1 ORACLE 311
12.1.1.1 Business overview 311
12.1.1.2 Products & services offered 312
12.1.1.3 Recent developments 314
12.1.1.3.1 Product launches & enhancements 314
12.1.1.3.2 Deals 314
12.1.1.4 MnM view 315
12.1.1.4.1 Key strengths 315
12.1.1.4.2 Strategic choices 315
12.1.1.4.3 Weaknesses & competitive threats 315
12.1.2 MERATIVE 316
12.1.2.1 Business overview 316
12.1.2.2 Products & services offered 316
12.1.2.3 Recent developments 317
12.1.2.3.1 Deals 317
12.1.2.4 MnM view 317
12.1.2.4.1 Right to win 317
12.1.2.4.2 Strategic choices 317
12.1.2.4.3 Weaknesses & competitive threats 317
12.1.3 SAS INSTITUTE INC. 318
12.1.3.1 Business overview 318
12.1.3.2 Products & services offered 318
12.1.3.3 Recent developments 319
12.1.3.3.1 Product launches & enhancements 319
12.1.3.3.2 Deals 319
12.1.3.4 MnM view 320
12.1.3.4.1 Right to win 320
12.1.3.4.2 Strategic choices 320
12.1.3.4.3 Weaknesses & competitive threats 320
12.1.4 ACCENTURE 321
12.1.4.1 Business overview 321
12.1.4.2 Products offered 323
12.1.4.3 Recent developments 323
12.1.4.3.1 Product launches & enhancements 323
12.1.4.3.2 Deals 324
12.1.4.4 MnM view 325
12.1.4.4.1 Right to win 325
12.1.4.4.2 Strategic choices 325
12.1.4.4.3 Weaknesses & competitive threats 325
12.1.5 IQVIA INC. 326
12.1.5.1 Business overview 326
12.1.5.2 Products & services offered 327
12.1.5.3 Recent developments 329
12.1.5.3.1 Product launches & enhancements 329
12.1.5.3.2 Deals 329
12.1.5.3.3 Other developments 330
12.1.5.4 MnM view 330
12.1.5.4.1 Right to win 330
12.1.5.4.2 Strategic choices 331
12.1.5.4.3 Weaknesses & competitive threats 331
12.1.6 COGNIZANT 332
12.1.6.1 Business overview 332
12.1.6.2 Products & services offered 333
12.1.6.3 Recent developments 335
12.1.6.3.1 Product launches & enhancements 335
12.1.6.3.2 Deals 335
12.1.7 WIPRO 337
12.1.7.1 Business overview 337
12.1.7.2 Products & services offered 338
12.1.7.3 Recent developments 340
12.1.7.3.1 Deals 340
12.1.8 VERADIGM LLC 341
12.1.8.1 Business overview 341
12.1.8.2 Products & services offered 342
12.1.8.3 Recent developments 343
12.1.8.3.1 Deals 343
?
12.1.9 OPTUM, INC. 344
12.1.9.1 Business overview 344
12.1.9.2 Products & services offered 345
12.1.9.3 Recent developments 345
12.1.9.3.1 Deals 345
12.1.10 MICROSOFT 346
12.1.10.1 Business overview 346
12.1.10.2 Products & services offered 347
12.1.10.3 Recent developments 348
12.1.10.3.1 Product launches & enhancements 348
12.1.10.3.2 Deals 348
12.1.11 MAXISIT 349
12.1.11.1 Business overview 349
12.1.11.2 Products & services offered 349
12.1.11.3 Recent developments 350
12.1.11.3.1 Product launches & enhancements 350
12.1.11.3.2 Deals 350
12.1.12 EXLSERVICE HOLDINGS, INC. 351
12.1.12.1 Business overview 351
12.1.12.2 Products & services offered 352
12.1.12.3 Recent developments 353
12.1.12.3.1 Product launches & enhancements 353
12.1.12.3.2 Deals 353
12.1.13 INOVALON 354
12.1.13.1 Business overview 354
12.1.13.2 Products & services offered 355
12.1.13.3 Recent developments 356
12.1.13.3.1 Product launches & enhancements 356
12.1.13.3.2 Deals 356
12.1.14 CITIUSTECH INC. 357
12.1.14.1 Business overview 357
12.1.14.2 Products & services offered 357
12.1.14.3 Recent developments 358
12.1.14.3.1 Product launches & enhancements 358
12.1.14.3.2 Deals 358
12.1.14.3.3 Expansions 359
12.1.15 SAAMA 360
12.1.15.1 Business overview 360
12.1.15.2 Products & services offered 360
12.1.15.3 Recent developments 361
12.1.15.3.1 Deals 361
?
12.1.16 AXTRIA 363
12.1.16.1 Business overview 363
12.1.16.2 Products & services offered 363
12.1.16.3 Recent developments 364
12.1.16.3.1 Product launches & enhancements 364
12.1.16.3.2 Deals 364
12.1.16.3.3 Expansions 364
12.1.17 CLARIVATE 365
12.1.17.1 Business overview 365
12.1.17.2 Products & services offered 367
12.1.17.3 Recent developments 368
12.1.17.3.1 Product launches & enhancements 368
12.1.17.3.2 Deals 368
12.1.18 THOUGHTSPHERE 369
12.1.18.1 Business overview 369
12.1.18.2 Products & services offered 370
12.1.18.3 Recent developments 370
12.1.18.3.1 Deals 370
12.1.19 THOUGHTSPOT INC. 371
12.1.19.1 Business overview 371
12.1.19.2 Products & services offered 371
12.1.19.3 Recent developments 372
12.1.19.3.1 Deals 372
12.1.19.3.2 Expansions 372
12.1.20 SALESFORCE, INC. 373
12.1.20.1 Business overview 373
12.1.20.2 Products & services offered 374
12.1.20.3 Recent developments 375
12.1.20.3.1 Product launches & enhancements 375
12.1.20.3.2 Deals 375
12.2 OTHER PLAYERS 376
12.2.1 GOOGLE LLC 376
12.2.2 AMAZON WEB SERVICES, INC. 377
12.2.3 VEEVA SYSTEMS 378
12.2.4 ELSEVIER 379
12.2.5 KOMODO HEALTH, INC. 380
?
13 APPENDIX 381
13.1 DISCUSSION GUIDE 381
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 386
13.3 CUSTOMIZATION OPTIONS 388
13.4 RELATED REPORTS 388
13.5 AUTHOR DETAILS 389
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 40
TABLE 2 LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT 55
TABLE 3 PHARMACEUTICAL COMPANIES IMPACTED BY CYBERINCIDENTS, 2024 69
TABLE 4 LIFE SCIENCE ANALYTICS MARKET: ROLE IN ECOSYSTEM 79
TABLE 5 LIFE SCIENCE ANALYTICS MARKET: PORTER'S FIVE FORCES 82
TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%) 85
TABLE 7 KEY BUYING CRITERIA FOR END USERS 86
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 89
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 89
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 12 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 13 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS,
BY APPLICATION 95
TABLE 14 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION 95
TABLE 15 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 96
TABLE 16 LIST OF PATENTS/PATENT APPLICATIONS 99
TABLE 17 UNMET NEEDS IN LIFE SCIENCE ANALYTICS MARKET 101
TABLE 18 END-USER EXPECTATIONS IN LIFE SCIENCE ANALYTICS MARKET 102
TABLE 19 MAJOR INVESTMENTS IN AI IN LIFE SCIENCE ANALYTICS MARKET 105
TABLE 20 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 118
TABLE 21 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 119
TABLE 22 PREDICTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 121
TABLE 23 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 122
TABLE 24 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 124
TABLE 25 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 125
TABLE 26 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 125
TABLE 27 MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 126
TABLE 28 MANAGED SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 127
TABLE 29 ANALYTICAL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 128
TABLE 30 CONSULTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 129
TABLE 31 PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 130
TABLE 32 PROFESSIONAL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 130
TABLE 33 TRAINING & IMPLEMENTATION SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 131
TABLE 34 MAINTENANCE & SUPPORT SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 132
TABLE 35 OTHER PROFESSIONAL SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 133
TABLE 36 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 134
TABLE 37 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION,
2022-2029 (USD MILLION) 135
TABLE 38 ON-PREMISE SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION) 136
TABLE 39 CLOUD-BASED SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION) 137
TABLE 40 SAAS-BASED SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION) 138
TABLE 41 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 140
TABLE 42 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE R&D SOLUTIONS 141
TABLE 43 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 142
TABLE 44 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION) 142
TABLE 45 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE CLINICAL
TRIAL SOLUTIONS 143
TABLE 46 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY REGION,
2022-2029 (USD MILLION) 144
TABLE 47 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 144
TABLE 48 LABORATORY SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 145
TABLE 49 PATIENT RECRUITMENT SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 146
TABLE 50 SITE IDENTIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 147
TABLE 51 OTHER CLINICAL TRIAL SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 148
TABLE 52 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE,
2022-2029 (USD MILLION) 149
TABLE 53 PHASE I CLINICAL TRIAL ANALYTICS MARKET, BY REGION,
2022-2029 (USD MILLION) 150
TABLE 54 PHASE II CLINICAL TRIAL ANALYTICS MARKET, BY REGION,
2022-2029 (USD MILLION) 151
TABLE 55 PHASE III CLINICAL TRIAL ANALYTICS MARKET, BY REGION,
2022-2029 (USD MILLION) 152
TABLE 56 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PRECLINICAL SOLUTIONS 153
TABLE 57 LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL & DRUG DISCOVERY,
BY REGION, 2022-2029 (USD MILLION) 154
TABLE 58 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE,
2022-2029 (USD MILLION) 155
TABLE 59 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY REGION, 2022-2029 (USD MILLION) 155
TABLE 60 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SALES & MARKETING SOLUTIONS 156
TABLE 61 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING SUPPORT,
BY REGION, 2022-2029 (USD MILLION) 157
TABLE 62 LIFE SCIENCE ANALYTICS MARKET FOR MARKET ACCESS, BY REGION,
2022-2029 (USD MILLION) 158
TABLE 63 LIFE SCIENCE ANALYTICS MARKET FOR RWE & VALUE EVIDENCE, BY REGION, 2022-2029 (USD MILLION) 159
TABLE 64 LIFE SCIENCE ANALYTICS MARKET FOR ENGAGEMENT SERVICES, BY REGION, 2022-2029 (USD MILLION) 160
TABLE 65 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS 161
TABLE 66 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2022-2029 (USD MILLION) 162
TABLE 67 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SUPPLY CHAIN OPTIMIZATION SOLUTIONS 163
TABLE 68 LIFE SCIENCE ANALYTICS MARKET FOR MANUFACTURING & SUPPLY CHAIN OPTIMIZATION, BY REGION, 2022-2029 (USD MILLION) 163
TABLE 69 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 164
TABLE 70 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY REGION,
2022-2029 (USD MILLION) 164
TABLE 71 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS 165
TABLE 72 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION,
2022-2029 (USD MILLION) 166
TABLE 73 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE SAFETY, BY REGION, 2022-2029 (USD MILLION) 167
TABLE 74 LIFE SCIENCE ANALYTICS MARKET FOR DIAGNOSTIC VIGILANCE, BY REGION, 2022-2029 (USD MILLION) 168
TABLE 75 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION) 170
TABLE 76 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 171
TABLE 77 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2029 (USD MILLION) 172
TABLE 78 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION,
2022-2029 (USD MILLION) 173
TABLE 79 LIFE SCIENCE ANALYTICS MARKET FOR OUTSOURCED LIFE SCIENCE ORGANIZATIONS, BY REGION, 2022-2029 (USD MILLION) 174
TABLE 80 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 176
TABLE 81 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 178
TABLE 82 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 179
TABLE 83 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 179
TABLE 84 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 179
TABLE 85 NORTH AMERICA: MANAGED SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 180
TABLE 86 NORTH AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 180
TABLE 87 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 180
TABLE 88 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 181
TABLE 89 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 90 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS,
BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 91 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS,
BY PHASE, 2022-2029 (USD MILLION) 182
TABLE 92 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 93 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 182
TABLE 94 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 183
TABLE 95 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 96 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 184
TABLE 97 US: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 184
TABLE 98 US: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 99 US: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 100 US: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 185
TABLE 101 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 185
TABLE 102 US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 103 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 186
TABLE 104 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE,
2022-2029 (USD MILLION) 186
TABLE 105 US: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 106 US: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 187
TABLE 107 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION) 187
TABLE 108 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 188
TABLE 109 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 189
TABLE 110 CANADA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 189
TABLE 111 CANADA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 112 CANADA: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 190
TABLE 113 CANADA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 190
TABLE 114 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 190
TABLE 115 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 116 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 117 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 191
TABLE 118 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 192
TABLE 119 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 192
TABLE 120 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 192
TABLE 121 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 194
TABLE 122 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 123 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 194
TABLE 124 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 195
TABLE 125 EUROPE: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 126 EUROPE: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 195
TABLE 127 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 196
TABLE 128 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 196
TABLE 129 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 130 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 131 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 197
TABLE 132 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 133 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 198
TABLE 134 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 198
TABLE 135 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 199
TABLE 136 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 199
TABLE 137 GERMANY: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 200
TABLE 138 GERMANY: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 200
TABLE 139 GERMANY: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 200
TABLE 140 GERMANY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 201
TABLE 141 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 201
TABLE 142 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 143 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 144 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 202
TABLE 145 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 146 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 203
TABLE 147 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 203
TABLE 148 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 149 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 204
TABLE 150 FRANCE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 204
TABLE 151 FRANCE: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 152 FRANCE: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 205
TABLE 153 FRANCE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 205
TABLE 154 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 206
TABLE 155 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 156 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 157 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 207
TABLE 158 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 159 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 207
TABLE 160 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 208
TABLE 161 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 162 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 209
TABLE 163 UK: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 209
TABLE 164 UK: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 165 UK: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 210
TABLE 166 UK: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 210
TABLE 167 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 210
TABLE 168 UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 169 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 211
TABLE 170 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE,
2022-2029 (USD MILLION) 211
TABLE 171 UK: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 172 UK: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 212
TABLE 173 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION) 212
TABLE 174 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 175 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 213
TABLE 176 ITALY: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 214
TABLE 177 ITALY: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 214
TABLE 178 ITALY: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 214
TABLE 179 ITALY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 215
TABLE 180 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 215
TABLE 181 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 215
TABLE 182 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 216
TABLE 183 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE,
2022-2029 (USD MILLION) 216
TABLE 184 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 185 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 217
TABLE 186 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 217
TABLE 187 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 188 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 218
TABLE 189 SPAIN: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 218
TABLE 190 SPAIN: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 191 SPAIN: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 192 SPAIN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 219
TABLE 193 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 219
TABLE 194 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 220
TABLE 195 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 220
TABLE 196 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE,
2022-2029 (USD MILLION) 220
TABLE 197 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 198 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 221
TABLE 199 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 221
TABLE 200 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 222
TABLE 201 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 222
TABLE 202 REST OF EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 223
TABLE 203 REST OF EUROPE: MANAGED SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 223
TABLE 204 REST OF EUROPE: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 223
TABLE 205 REST OF EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 224
TABLE 206 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 224
TABLE 207 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 208 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS,
BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 209 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS,
BY PHASE, 2022-2029 (USD MILLION) 225
TABLE 210 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 211 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION) 226
TABLE 212 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 226
TABLE 213 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 229
TABLE 214 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 229
TABLE 215 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 229
TABLE 216 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 230
TABLE 217 ASIA PACIFIC: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 230
TABLE 218 ASIA PACIFIC: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 230
TABLE 219 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 231
TABLE 220 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 231
TABLE 221 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 231
TABLE 222 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 223 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 232
TABLE 224 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 225 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 233
TABLE 226 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 233
TABLE 227 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 228 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 234
TABLE 229 JAPAN: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 235
TABLE 230 JAPAN: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 231 JAPAN: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 232 JAPAN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 236
TABLE 233 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 236
TABLE 234 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 236
TABLE 235 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 237
TABLE 236 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 237
TABLE 237 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 238 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 238
TABLE 239 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 238
TABLE 240 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 241 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 239
TABLE 242 CHINA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 239
TABLE 243 CHINA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 244 CHINA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 245 CHINA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 240
TABLE 246 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 241
TABLE 247 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 248 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 241
TABLE 249 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 242
TABLE 250 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 251 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 242
TABLE 252 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 243
TABLE 253 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 244
TABLE 254 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 244
TABLE 255 INDIA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 244
TABLE 256 INDIA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 244
TABLE 257 INDIA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 258 INDIA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 245
TABLE 259 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 245
TABLE 260 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 261 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 246
TABLE 262 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE,
2022-2029 (USD MILLION) 246
TABLE 263 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 247
TABLE 264 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 247
TABLE 265 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 247
TABLE 266 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 248
TABLE 267 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 249
TABLE 268 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 249
TABLE 269 REST OF ASIA PACIFIC: MANAGED SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 249
TABLE 270 REST OF ASIA PACIFIC: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 250
TABLE 271 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 250
TABLE 272 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 250
TABLE 273 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 251
TABLE 274 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 251
TABLE 275 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 251
TABLE 276 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 277 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 278 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 252
TABLE 279 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 254
TABLE 280 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 254
TABLE 281 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 254
TABLE 282 LATIN AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 255
TABLE 283 LATIN AMERICA: MANAGED SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 255
TABLE 284 LATIN AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 255
TABLE 285 LATIN AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 256
TABLE 286 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 256
TABLE 287 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 256
TABLE 288 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 257
TABLE 289 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS,
BY PHASE, 2022-2029 (USD MILLION) 257
TABLE 290 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 257
TABLE 291 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 258
TABLE 292 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 258
TABLE 293 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 259
TABLE 294 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 259
TABLE 295 BRAZIL: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 259
TABLE 296 BRAZIL: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 260
TABLE 297 BRAZIL: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 260
TABLE 298 BRAZIL: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 260
TABLE 299 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 261
TABLE 300 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 261
TABLE 301 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 261
TABLE 302 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 262
TABLE 303 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 262
TABLE 304 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 262
TABLE 305 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 263
TABLE 306 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 264
TABLE 307 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 264
TABLE 308 MEXICO: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 264
TABLE 309 MEXICO: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 265
TABLE 310 MEXICO: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 265
TABLE 311 MEXICO: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 265
TABLE 312 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 266
TABLE 313 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT,
BY TYPE, 2022-2029 (USD MILLION) 266
TABLE 314 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE,
2022-2029 (USD MILLION) 266
TABLE 315 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 267
TABLE 316 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS,
BY TYPE, 2022-2029 (USD MILLION) 267
TABLE 317 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 267
TABLE 318 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 268
TABLE 319 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 269
TABLE 320 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 269
TABLE 321 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 269
TABLE 322 REST OF LATIN AMERICA: MANAGED SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 270
TABLE 323 REST OF LATIN AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 270
TABLE 324 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 270
TABLE 325 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 271
TABLE 326 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 271
TABLE 327 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 271
TABLE 328 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 272
TABLE 329 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 272
TABLE 330 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION) 272
TABLE 331 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION) 273
TABLE 332 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY REGION,
2022-2029 (USD MILLION) 274
TABLE 333 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 274
TABLE 334 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 275
TABLE 335 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 275
TABLE 336 MIDDLE EAST & AFRICA: MANAGED SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 275
TABLE 337 MIDDLE EAST & AFRICA: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 276
TABLE 338 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 276
TABLE 339 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 276
TABLE 340 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 277
TABLE 341 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 277
TABLE 342 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 277
TABLE 343 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 278
TABLE 344 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION) 278
TABLE 345 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 278
TABLE 346 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 279
TABLE 347 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 280
TABLE 348 GCC COUNTRIES: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 280
TABLE 349 GCC COUNTRIES: MANAGED SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 280
TABLE 350 GCC COUNTRIES: PROFESSIONAL SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 281
TABLE 351 GCC COUNTRIES: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 281
TABLE 352 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 281
TABLE 353 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 282
TABLE 354 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS,
BY TYPE, 2022-2029 (USD MILLION) 282
TABLE 355 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS,
BY PHASE, 2022-2029 (USD MILLION) 282
TABLE 356 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 283
TABLE 357 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE,
2022-2029 (USD MILLION) 283
TABLE 358 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 283
TABLE 359 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 284
TABLE 360 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET,
BY COMPONENT, 2022-2029 (USD MILLION) 284
TABLE 361 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SERVICES MARKET,
BY TYPE, 2022-2029 (USD MILLION) 285
TABLE 362 REST OF MIDDLE EAST & AFRICA: MANAGED SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 285
TABLE 363 REST OF MIDDLE EAST & AFRICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 285
TABLE 364 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 286
TABLE 365 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 286
TABLE 366 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET
FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION) 286
TABLE 367 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION) 287
TABLE 368 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION) 287
TABLE 369 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET
FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION) 287
TABLE 370 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION) 288
TABLE 371 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET,
BY END USER, 2022-2029 (USD MILLION) 288
TABLE 372 LIFE SCIENCE ANALYTICS MARKET: DEGREE OF COMPETITION 292
TABLE 373 LIFE SCIENCE ANALYTICS MARKET: TYPE FOOTPRINT (25 COMPANIES) 297
TABLE 374 LIFE SCIENCE ANALYTICS MARKET: APPLICATION FOOTPRINT (25 COMPANIES) 298
TABLE 375 LIFE SCIENCE ANALYTICS MARKET: COMPONENT FOOTPRINT (25 COMPANIES) 299
TABLE 376 LIFE SCIENCE ANALYTICS MARKET: END USER FOOTPRINT (25 COMPANIES) 300
TABLE 377 LIFE SCIENCE ANALYTICS MARKET: REGION FOOTPRINT (25 COMPANIES) 301
TABLE 378 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 304
TABLE 379 LIFE SCIENCE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES) 305
TABLE 380 LIFE SCIENCE ANALYTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025 308
TABLE 381 LIFE SCIENCE ANALYTICS MARKET: DEALS, JANUARY 2021-JANUARY 2025 309
TABLE 382 ORACLE: COMPANY OVERVIEW 311
TABLE 383 ORACLE: PRODUCTS & SERVICES OFFERED 312
TABLE 384 ORACLE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 314
TABLE 385 ORACLE: DEALS, JANUARY 2021-JANUARY 2025 314
TABLE 386 MERATIVE: COMPANY OVERVIEW 316
TABLE 387 MERATIVE: PRODUCTS & SERVICES OFFERED 316
TABLE 388 MERATIVE: DEALS, JANUARY 2021-JANUARY 2025 317
TABLE 389 SAS INSTITUTE: COMPANY OVERVIEW 318
TABLE 390 SAS INSTITUTE: PRODUCTS & SERVICES OFFERED 318
TABLE 391 SAS INSTITUTE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 319
TABLE 392 SAS INSTITUTE: DEALS, JANUARY 2021-JANUARY 2025 319
TABLE 393 ACCENTURE: COMPANY OVERVIEW 321
TABLE 394 ACCENTURE: PRODUCTS OFFERED 323
TABLE 395 ACCENTURE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-DECEMBER 2025 323
TABLE 396 ACCENTURE: DEALS, JANUARY 2021-JANUARY 2025 324
TABLE 397 IQVIA: COMPANY OVERVIEW 326
TABLE 398 IQVIA: PRODUCTS & SERVICES OFFERED 327
TABLE 399 IQVIA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025 329
TABLE 400 IQVIA: DEALS, JANUARY 2021-JANUARY 2025 329
TABLE 401 IQVIA: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 330
TABLE 402 COGNIZANT: COMPANY OVERVIEW 332
TABLE 403 COGNIZANT: PRODUCTS & SERVICES OFFERED 333
TABLE 404 COGNIZANT: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 335
TABLE 405 COGNIZANT: DEALS, JANUARY 2021-JANUARY 2025 335
TABLE 406 WIPRO: COMPANY OVERVIEW 337
TABLE 407 WIPRO: PRODUCTS & SERVICES OFFERED 338
TABLE 408 WIPRO: DEALS, JANUARY 2021-JANUARY 2025 340
TABLE 409 VERADIGM: COMPANY OVERVIEW 341
TABLE 410 VERADIGM: PRODUCTS & SERVICES OFFERED 342
TABLE 411 VERADIGM: DEALS, JANUARY 2021-JANUARY 2025 343
TABLE 412 OPTUM: COMPANY OVERVIEW 344
TABLE 413 OPTUM: PRODUCTS & SERVICES OFFERED 345
TABLE 414 OPTUM: DEALS, JANUARY 2021-JANUARY 2025 345
TABLE 415 MICROSOFT: COMPANY OVERVIEW 346
TABLE 416 MICROSOFT: PRODUCTS & SERVICES OFFERED 347
TABLE 417 MICROSOFT: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 348
TABLE 418 MICROSOFT: DEALS, JANUARY 2021-JANUARY 2025 348
TABLE 419 MAXISIT: COMPANY OVERVIEW 349
TABLE 420 MAXISIT: PRODUCTS & SERVICES OFFERED 349
TABLE 421 MAXISIT: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 350
TABLE 422 MAXISIT: DEALS, JANUARY 2021-JANUARY 2025 350
TABLE 423 EXLSERVICE HOLDINGS: COMPANY OVERVIEW 351
TABLE 424 EXLSERVICE HOLDINGS: PRODUCTS & SERVICES OFFERED 352
TABLE 425 EXLSERVICE HOLDINGS: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025 353
TABLE 426 EXLSERVICE HOLDINGS: DEALS, JANUARY 2021-JANUARY 2025 353
TABLE 427 INOVALON: COMPANY OVERVIEW 354
TABLE 428 INOVALON: PRODUCTS & SERVICES OFFERED 355
TABLE 429 INOVALON: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 356
TABLE 430 INOVALON: DEALS, JANUARY 2021-JANUARY 2025 356
TABLE 431 CITIUSTECH: COMPANY OVERVIEW 357
TABLE 432 CITIUSTECH: PRODUCTS & SERVICES OFFERED 357
TABLE 433 CITIUSTECH: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 358
TABLE 434 CITIUSTECH: DEALS, JANUARY 2021-JANUARY 2025 358
TABLE 435 CITIUSTECH: EXPANSIONS, JANUARY 2021-JANUARY 2025 359
TABLE 436 SAAMA: COMPANY OVERVIEW 360
TABLE 437 SAAMA: PRODUCTS & SERVICES OFFERED 360
TABLE 438 SAAMA: DEALS, JANUARY 2021-JANUARY 2025 361
TABLE 439 AXTRIA: COMPANY OVERVIEW 363
TABLE 440 AXTRIA: PRODUCTS & SERVICES OFFERED 363
TABLE 441 AXTRIA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025 364
TABLE 442 AXTRIA: DEALS, JANUARY 2021-JANUARY 2025 364
TABLE 443 AXTRIA: EXPANSIONS, JANUARY 2021-JANUARY 2025 364
TABLE 444 CLARIVATE: COMPANY OVERVIEW 365
TABLE 445 CLARIVATE: PRODUCTS & SERVICES OFFERED 367
TABLE 446 CLARIVATE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 368
TABLE 447 CLARIVATE: DEALS, JANUARY 2021-JANUARY 2025 368
TABLE 448 THOUGHTSPHERE: COMPANY OVERVIEW 369
TABLE 449 THOUGHTSPHERE.: PRODUCTS & SERVICES OFFERED 370
TABLE 450 THOUGHTSPHERE.: DEALS, JANUARY 2021-JANUARY 2025 370
TABLE 451 THOUGHTSPOT: COMPANY OVERVIEW 371
TABLE 452 THOUGHTSPOT: PRODUCTS & SERVICES OFFERED 371
TABLE 453 THOUGHTSPOT: DEALS, JANUARY 2021-JANUARY 2025 372
TABLE 454 THOUGHTSPOT: EXPANSIONS, JANUARY 2021-JANUARY 2025 372
TABLE 455 SALESFORCE: COMPANY OVERVIEW 373
TABLE 456 SALESFORCE: PRODUCTS & SERVICES OFFERED 374
TABLE 457 SALESFORCE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-DECEMBER 2024 375
TABLE 458 SALESFORCE: DEALS, JANUARY 2021-JANUARY 2025 375
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security